BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 118317
Published online Jun 27, 2026. doi: 10.4240/wjgs.118317
Table 1 Comparison of baseline data between the mirabilite and control groups, n (%)/mean ± SD
Variable
Mirabilite group
Control group
P value
Gender0.688
    Male92 (30.56)97 (32.23)
    Female58 (19.27)54 (17.94)
Age, years60.82 ± 10.4961.52 ± 10.190.620
BMI, kg/m222.87 ± 2.9222.80 ± 2.950.706
ASA0.577
    II13 (4.32)17 (5.64)
    III137 (45.51)134 (44.52)
Comorbidities
    Diabetes mellitus16 (10.67)18 (11.92)0.731
    Chronic lung disease11 (7.33)10 (6.62)0.783
    Hypertension22 (14.67)25 (16.56)0.654
    Coronary heart disease7 (4.67)6 (3.97)0.741
    Preoperative hypoalbuminemia (< 35 g/L)14 (9.33)18 (11.92)0.467
Surgical site0.426
    Stomach54 (17.94)61 (20.26)
    Rectum45 (14.95)45 (14.95)
    Right hemicolon26 (8.64)17 (5.65)
    Left hemicolon9 (2.99)6 (1.99)
    Sigmoid colon16 (5.31)22 (7.31)


Write to the Help Desk